What if pharma threw a party in China but the government refused to come? Well, that’s just what might happen as a result of new rules that give domestic companies preference in government purchasing. The Obama Administration is up in arms about the regulations, saying that they amount to trade barriers, Bloomberg reports. “The United States has since expressed serious concerns to China about this measure,” The U.S. trade rep said in a report (as quoted by Bloomberg ), going on to say that for the past two years China has been pursuing “industrial policies that rely on excessive, trade-distorting government intervention intended to promote or protect China’s domestic industries.” China is the big-gorilla buyer of drugs in that market, so Big Pharma’s push into the country relies in part on getting government business. And the globe’s biggest drugmakers are targeting China in a big way. Eli Lilly is staffing up on the sales side to garner more business there; Novartis